One possible explanation of how 2-AG could modulate the chemotaxis to CXCL12 is to impair the ability of the CXCR4 receptor to internalize and signal upon CXCL12 binding, as described in breast and prostate cancer [37]. The gene discussed is CXCL12; the disease is Familial prostate cancer.